Martin Sean
- SEC CIK
- 0001500332
No open-market purchases or sales filed in the past year.
Current role at each company
- GENB Generate Biomedicines, Inc.Chief Legal Officer & GCas of Mar 2, 2026
- BAX Baxter International IncSVP and General Counselas of Mar 4, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Martin Sean as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
BAX Baxter International Inc
SVP and General Counsel2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 3, 2021 (view filing) | Nov 1 | 2 days | Martin SeanSVP and General Counsel | SSaleCommon Stock, $1 par value | −21.4K | $79.57 | −$1.71M | −33.7%42.3K after | 2 lots |
| Aug 4, 2021 (view filing) | Aug 2 | 2 days | Martin SeanSVP and General Counsel | SSaleCommon Stock, $1 par value | −19.8K | $77.26 | −$1.53M | −31.9%42.2K after |